Dawonsys Co.,Ltd.

Dawonsys Co.,Ltd.

068240.KQ
Dawonsys Co.,Ltd.KR flagKOSDAQ
2,530.00
KRW
+45.00
- -
96.55BMarket Cap
Dawonsys Co.,Ltd.
068240.KQ
(KOSDAQ)

Recent

price

2,530.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
2,174.87
2,363.76
2,854.38
2,905.43
2,856.93
3,184.17
2,875.89
4,618.15
4,913.54
6,125.18
8,228.27
9,558.72
6,152.73
10,164.68
8,175.65
2,936.88
2,334.38
Revenue per Share
387.94
218.35
318.17
318.76
318.17
403.68
273.22
262.15
303.68
148.61
492.91
-572.07
-4,443.22
108.37
306
-5,162
-3,748.06
Basic EPS, GAAP
-1,184.9
247.48
-346.72
-159.92
-483
-1,270.7
-1,880.7
-1,697.37
-402.76
2,421.62
-1,361.15
-4,627.15
-4,661.2
-296.53
-1,954.53
-3,343.72
-3,335.87
Free Cash Flow per Basic Share
- -
42.91
35.99
33.76
34.94
34.01
30.54
49.6
45.68
45.03
88.16
85.97
45.77
- -
- -
19.65
- -
Dividend per Share
1,210.96
1,225.46
1,521.5
1,742.72
1,961.95
2,190.54
2,192
2,568.05
2,574.36
2,802.98
3,417.37
2,846.97
-1,858.18
-1,720.68
-1,313.07
-21,685.4
-20,768.96
Book Value per Share
2,172.44
1,776.84
2,098.96
2,449.4
2,897.85
5,621.25
4,287.81
4,928.24
5,273.16
5,426.51
5,953.81
7,392.16
4,995.9
5,088.54
6,216.21
-13,711.33
-12,915.79
Tangible Book Value per Share
14
17
17
18
19
21
26
24
26
29
30
31
34
35
37
38
38
Basic Weighted Avg Shares
30,403
39,573
47,642
51,369
53,005
67,001
74,194
111,462
128,748
175,077
247,950
295,454
209,189
357,844
301,518
112,089
89,088
Sales/Revenue/Turnover
16.4
12.63
14.95
14.04
13.21
11.85
12.45
7.92
6.75
4.72
6.62
-4.9
-76.14
5.39
2.54
-107.66
-130.12
Operating Margin (%)
1,273
1,534
1,731
1,778
1,924
2,224
2,956
7,143
10,268
14,747
19,878
22,030
21,170
19,694
17,165
14,369
13,895
Depreciation Expense
5,423
3,656
5,310
5,636
5,903
8,494
7,049
6,327
7,957
4,248
14,853
-17,682
-151,066
3,815
11,285
-197,013
-143,039
Net Income, GAAP
16.34
13.08
3.33
10.71
17.09
9.72
9.18
18.25
- -
9.54
- -
- -
- -
18.17
26.57
- -
0.29
Effective Tax Rate (%)
17.84
9.24
11.15
10.97
11.14
12.68
9.5
5.68
6.18
2.43
5.99
-5.98
-72.22
1.07
3.74
-175.76
-160.56
Profit Margin (%)
20,957
34,761
19,537
29,908
36,461
90,109
75,613
66,725
71,773
32,978
34,412
83,076
-24,553
6,647
31,916
-724,007
-723,296
Working Capital
3,270
21,906
8,800
16,212
25,693
33,828
33,893
39,369
38,249
66,888
67,405
82,072
81,518
94,017
86,009
90,025
85,625
LT Debt
34,084
38,750
43,300
52,512
63,683
132,167
139,085
179,123
199,642
210,744
222,578
268,297
205,482
211,184
258,929
-515,642
-485,211
Total Equity
13.44
8.46
10.03
8.36
6.23
4.94
4.22
2.83
- -
2.3
- -
- -
- -
3.57
1.12
- -
- -
Return on Invested Capital (%)
29.3
14.6
14.42
11.39
8.88
10.68
7.59
6.32
- -
4.29
- -
- -
- -
9.21
10.43
- -
129.51
Return on Capital (%)
40.18
19.53
23.13
20.05
17.57
20.59
13.73
10.68
12.3
5.76
16.22
-18.52
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
196,050
318,038
287,323
LT Borrowings
127,346
89,309
85,369
LT Finance Leases
781
716
256
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
38
38
38
Market Capitalization
188,902
92,352
96,553

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
409,300
304,855
286,791
Cash, Cash Equivalents & STI
27,400
44,950
12,724
Accounts Receivable, Net
275,235
90,084
89,775
Inventories
38,050
116,952
130,220
Total Current Liabilities
415,870
1,028,862
1,010,087
Payables & Accruals
- -
- -
- -
ST Debt
196,050
318,038
287,323
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-22%
-55.33%
-299.14%
Free Cash Flow
-8.98%
166.73%
77.04%
Net Income, GAAP
-101.56%
-243.44%
-1,845.75%
Sales/Revenue/Turnover
13.65%
-3.51%
-62.83%
Total Cash Common Dividend
- -
- -
-51.81%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
54,154
96,980
73,890
76,494
301,518
2025
43,975
35,463
27,994
4,657
112,089
2026
20,973
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
313
350
-32
- -
306
2025
-520
-505.23
-496.14
- -
-5,162
2026
894.35
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
19.65
- -
- -
- -
19.65
2026
- -
- -
- -
- -
- -
Business
Dawonsys Co.,Ltd. is a prominent player in the power electronics sector, specializing in the manufacture of advanced power supplies and electronic induction heating systems. The company operates across five key business divisions: rolling stock, fusion power supply and accelerators, display and semiconductors, industrial plant and intelligent welding, and eco-friendly systems. In its rolling stock segment, Dawonsys develops and produces railway vehicles and their electrical components, including power supplies for electric trains, contributing to various subway lines in Seoul and other national rail projects. The fusion power supply and accelerator division focuses on critical components for large-scale scientific endeavors, such as international thermal-nuclear experimental reactors and advanced particle accelerators for research and medical applications, offering high-precision magnetic power supplies and pulse modulators. Within the display and semiconductor field, the company provides specialized equipment for manufacturing processes, including innovative OLED deposition technology and atmospheric plasma systems used for surface cleaning. The plant and intelligent welding segment delivers comprehensive engineering solutions for industrial applications, encompassing systems like continuous galvanizing and color coating lines, as well as industrial rectifiers for chemical and steel production, alongside welding solutions for the automotive industry. Finally, its environment-friendly system division designs and implements solutions for energy storage, plasma torch applications, and micro pulse systems for electrostatic precipitators, all aimed at enhancing environmental sustainability. Established in 1996 and headquartered in Ansan, South Korea, Dawonsys has expanded its reach both domestically and internationally. Recent activities include significant contracts for electric train supply for Seoul Metro and KORAIL in 2023 and 2024, alongside clinical approval for Boron Neutron Capture Therapy (A-BNCT) through its DawonMedax subsidiary in 2022. Dawonsys is recognized for its foundational expertise in basic science, which it leverages to drive innovation in high-tech industries.